DD D&D PHARMATECH

Serial Number 97120139
602

Registration Progress

Application Filed
Nov 11, 2021
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

DD D&D PHARMATECH

Basic Information

Serial Number
97120139
Filing Date
November 11, 2021
Abandonment Date
November 21, 2023
Drawing Code
5000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Dec 21, 2023
Classes
042

Rights Holder

D&D Pharmatech, Inc.

03
Address
5th Floor, I&C Building, 24, Pangyo-ro
255 beon-gil, Bundang-gu, Seongnam-si
Gyeonggi-do 13486
KR

Ownership History

D&D Pharmatech, Inc.

Original Applicant
03
Gyeonggi-do KR

Legal Representation

Attorney
Todd S. Bontemps

Application History

17 events
Date Code Type Description Documents
Dec 21, 2023 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Dec 21, 2023 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Dec 21, 2023 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Aug 16, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Aug 16, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
May 20, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 20, 2023 GNRT O NON-FINAL ACTION E-MAILED Loading...
May 20, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 23, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 22, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 22, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 29, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 29, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 29, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 23, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 18, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 15, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmaceutical research and development; Medical and scientific research in the field of cancer, neurological diseases, fibrotic diseases, metabolic diseases, cancer, ischemia, and ophthalmic diseases and disorders
First Use Anywhere: Dec 28, 2014
First Use in Commerce: Dec 28, 2014

Additional Information

Design Mark
The mark consists of the stylized letters DD appearing adjacent, with one letter D facing in reverse direction. The stylized letters DD appear to the left of the wording D&D PHARMATECH in stylized lettering. The wording D&D PHARMATECH appears in a stacked format, with the letters D&D appearing over the word PHARMATECH.
Pseudo Mark
DD D AND D PHARMATECH

Classification

International Classes
042